Trio Labs has filed a notice of an exempt offering of securities to raise $8,000,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Trio Labs is raising $8,000,000.00 in new funding. Sources indicate that as part of senior management President, Adam Steege played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Trio Labs
Trio Labs mission is to improve lives by enabling the next generation of medical devices. Trio fabricates precision metal parts with unmatched fine resolution that scale seamlessly from prototyping though high volume manufacturing. The Resin Infused Powder Lithography (RIPL) process reduces costs and manufacturing times for existing products, and enables wholly new solutions in a wide range of medical device markets such as high precision surgical tools, interventional devices, miniaturized infusion pumps, microneedle arrays, drug delivery devices, and more.
To learn more about Trio Labs, visit http://www.triolabs.com/
Contact:
Adam Steege, President
919-818-9646
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.